SD

Smrithi Deora

Active Director Director DIN 02597895
DIN 02597895 First appointment Apr 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2007
Shareholding value •••• Premium profile

About Smrithi Deora

Data last updated:

Smrithi Deora is a Director at Siesta Life Sciences And Drugs Private Limited (since 2007). The company operates in Pharma. Siesta Life Sciences And Drugs Private Limited reported revenue of ₹48.2 Lakh (FY 2024).

DIN 02597895
Primary Designation Director
Industry Pharma
First Appointment 13 Apr 2007
Oldest Company Age 19 yrs
Largest company Siesta Life Sciences And Drugs Private Limited · ₹48.2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Apr 20072007₹48.2 Lakh (FY 2024)Active

Board colleagues of Smrithi Deora

Directorship timeline

Open interactive timeline →
Siesta Life Sciences And Drugs Private Limited
Premium access

Shareholding and investment profile for Smrithi Deora

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Smrithi Deora

Smrithi Deora currently holds 1 directorship: Siesta Life Sciences And Drugs Private Limited (Director, since 13 Apr 2007, revenue ₹48.2 Lakh (FY 2024)).

Smrithi Deora was first appointed on 13 Apr 2007 as Director at Siesta Life Sciences And Drugs Private Limited.

The current boards of Smrithi Deora's companies include Vikram Singh Deora (Siesta Life Sciences And Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available